First patient treated with Leqembi in Sweden via private clinic
BioArctic AB said Leqembi (lecanemab) is now available at a private clinic in Sweden, with the first patient starting treatment.
BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) said today that Leqembi is now available at a private clinic in Sweden, and that the first patient has started treatment. The company said this is the first time a patient in Sweden has been treated outside of a clinical study. The announcement was dated Sept. 22, 2026.